A committee of experts managed by America’s regulators or the Food and Drug Administration (FDA) voted 20-2 to let Vivus Inc to market the next generation of weight-loss capsule called Qnexa. Qnexa is a capsule to be taken once-a-day. The biopharmaceutical company is located in the technology hub of Silicon Valley's Mountain View.
The controlled-release pill for treating obesity is a combination of two types of drugs. First, a drug called stimulant phentermine which is used to help lowering appetite on patient. Second, another drug called topiramate which is used to escalate of feeling full in the patient's tummy.
(Image: vivus.com)